Growth Metrics

Emergent BioSolutions (EBS) Amortization of Goodwill (2022 - 2023)

Historic Amortization of Goodwill for Emergent BioSolutions (EBS) over the last 2 years, with Q3 2023 value amounting to $218.2 million.

  • Emergent BioSolutions' Amortization of Goodwill changed N/A to $218.2 million in Q3 2023 from the same period last year, while for Dec 2024 it was $218.2 million, marking a year-over-year decrease of 297.91%. This contributed to the annual value of $218.2 million for FY2023, which is 315671.64% up from last year.
  • Per Emergent BioSolutions' latest filing, its Amortization of Goodwill stood at $218.2 million for Q3 2023.
  • Emergent BioSolutions' Amortization of Goodwill's 5-year high stood at $218.2 million during Q3 2023, with a 5-year trough of $6.7 million in Q4 2022.